Order results by:
| Issue | Title | |
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS | Abstract similar documents |
| O. L. Barbarash, M. V. Zykov | ||
| "... metoprolol tartrate (CRMT) in patients with arterial hypertension of 1-3 degree. Material and methods. 603 ..." | ||
| Vol 7, No 6 (2011) | EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS | Abstract similar documents |
| V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova | ||
| "... .3;8.3); p<0.01; L-CAVI1 from 8.9 (7.6;9.9) to 7.9 (7.2;8.5), p<0.001. Conclusion. Metoprolol tartrate ..." | ||
| Vol 6, No 3 (2010) | WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL? | Abstract similar documents |
| E. V. Kuleshova | ||
| "... Relationship of metoprolol clinical efficacy with its different salts (tartrate, succinate ..." | ||
| Vol 5, No 2 (2009) | COMPARISON BETAXOLOL AND METOPROLOL TARTRATE THERAPIES IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH STABLE ANGINA | Abstract similar documents |
| A. A. Anderzhanova, J. V. Gavrilov, V. A. Sulimov | ||
| "... adrenoblockers (betaxolol and metoprolol tartrate) in patients with arterial hypertension (HT) of 1-2 degree ..." | ||
| Vol 1, No 3 (2005) | COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION | Abstract similar documents |
| J. V. Lukina, A. D. Deev, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, G. F. Andreeva, S. Y. Martsevich | ||
| "... Aim. To study efficiency and safety of new drug of long acting metoprolol tartrate, “Egilok retard ..." | ||
| Vol 6, No 2 (2010) | EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION | Abstract PDF (Eng) similar documents |
| A. N. Zakirova, B. N. Garifullin, F. S. Zarudij, N. E. Zakirova | ||
| "... Aim. To study influence of beta-blockers carvedilol and metoprolol tartrate on platelet ..." | ||
| Vol 4, No 5 (2008) | CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| M. V. Soura | ||
| "... ’s comparative cost analysis on metoprolol tartrate (Betaloc) and metoprolol succinate (Betaloc ZOK) usage ..." | ||
| Vol 3, No 3 (2007) | TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY | Abstract similar documents |
| V. E. Oleinikov, V. A. Budanova, A. V. Kulyutsin | ||
| "... heart rate variability (HRV) and efficacy of metoprolol tartrate in long-acting presentation (Egilok ..." | ||
| Vol 5, No 4 (2009) | METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER | Abstract similar documents |
| B. N. Garifullin, A. N. Zakirova, F. S. Zarudij | ||
| "... of metoprolol tartrate and carvedilol on MI pathogenesis are presented. Possible indications and treatment ..." | ||
| Vol 3, No 5 (2007) | EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| I. V. Vologdina | ||
| "... Aim. To study effect of cardioselective β-adrenoblocker emmetoprolol/em emtartrate/em (in retarded ..." | ||
| Vol 4, No 1 (2008) | EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE | Abstract similar documents |
| S. A. Smakotina, O. A. Trubnikova, O. L. Barbarash | ||
| "... Aim. To evaluate the effect of emmetoprolol/em emtartrate/em on blood pressure (BP) and cognitive function ..." | ||
| Vol 6, No 4 (2010) | PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov | ||
| "... on carvedilol or emmetoprolol/em in patients with arterial hypertension (HT) 1-2 degrees and overweight/obesity ..." | ||
| Vol 4, No 5 (2008) | EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... on emmetoprolol/em. Patients were randomized in 2 groups (G1 and G2). The initial emmetoprolol/em dose was 50 mg in G1 ..." | ||
| Vol 5, No 2 (2009) | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich | ||
| "... ,26±0,10kg/m2 (рem0,01/em) in emmetoprolol/em group. Carvedilol in comparison with emmetoprolol/em had more positive ..." | ||
| Vol 5, No 1 (2009) | COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina | ||
| "... ) in comparison with emmetoprolol/em (M) in hypertensive patients with overweight or obesity. Material and methods ..." | ||
| Vol 5, No 4 (2009) | EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH RENOPARENCHYMAL ARTERIAL HYPERTENSION IN ACTUAL CLINICAL PRACTICE | Abstract similar documents |
| N. J. Borovkova, N. N. Borovkov, T. I. Maslov | ||
| "... , emmetoprolol/em emtartrate/em, amlodipine bensilate and rilmenidine dihydrogen phosphate in hypertensive patients ..." | ||
| Vol 4, No 4 (2008) | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST | Abstract similar documents |
| L. N. Malaj | ||
| "... is surveyed. Author presents a review of data about selective β1-blocker, emmetoprolol/em succinate (Betalok ZОК ..." | ||
| Vol 8, No 6 (2012) | TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE | Abstract similar documents |
| O. D. Ostroumova, G. N. Shchukina, V. M. Fomina | ||
| "... Advantages of emmetoprolol/em succinate in patients with chronic heart failure (CHF) are covered ..." | ||
| Vol 5, No 3 (2009) | EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS | Abstract similar documents |
| A. R. Kiselev, V. I. Gridnev, A. S. Karavaev, O. M. Posnenkova, V. A. Shvarts, V. I. Ponomarenko, M. D. Prokhorov, B. P. Bezruchko | ||
| "... Aim. To study effects of carvedilol and emmetoprolol/em on vegetative regulation of heart ..." | ||
| Vol 3, No 4 (2007) | EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova | ||
| "... – emmetoprolol/em (Metocard), 50-200 mg/d. Diuretics were added when necessary. Ambulatory blood pressure (BP ..." | ||
| Vol 6, No 3 (2010) | ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY | Abstract similar documents |
| V. A. Nevzorova, E. S. Potapova, O. V. Nastradin | ||
| "... or emmetoprolol/em and its influence on markers of blood oxidative status in hypertensive patients with overweight ..." | ||
| Vol 17, No 3 (2021) | Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome | Abstract similar documents |
| A. Yu. Proshlyakov, P. Sh. Chomakhidze, N. A. Novikova | ||
| Vol 2, No 3 (2006) | EFFECTS OF AMLODIPIN AND METOPROLOL ON AUTONOMIC SYSTEM IN EMOTIONAL AND COLD TESTS IN HYPERTENSIVE PATIENTS WITH DIFFERENT PSYCHOLOGICAL PROFILE | Abstract similar documents |
| M. P. Rubanova, V. R. Veber, I. A. Suhenko, P. M. Gubskaya | ||
| "... Aim. To asses effects of amlodipin and emmetoprolol/em on autonomic system in emotional and cold tests ..." | ||
| Vol 12, No 6 (2016) | THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev | ||
| "... . All patients in the study received emmetoprolol/em emtartrate/em (100 mg daily). Nicorandil was added (10 mg BID ..." | ||
| Vol 4, No 1 (2008) | VASCULAR REMODELING AND HEART RATE VARIABILITY IN DIFFERENT ANTIHYPERTENSIVE THERAPIES | Abstract similar documents |
| E. D. Golovanova | ||
| "... Retard, 1,5 mg/d), emmetoprolol/em emtartrate/em (Egilok Retard, 50 mg/d) and combined therapy with indapamide ..." | ||
| Vol 7, No 6 (2011) | INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY | Abstract similar documents |
| V. G. Tregubov, S. G. Kanorskiy, V. M. Pokrovskiy | ||
| "... Aim. To estimate emmetoprolol/em succinate effect on regulatory and adaptive status (RAS) of patients ..." | ||
| Vol 3, No 2 (2007) | NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS | Abstract similar documents |
| Y. V. Gavrilov, V. A. Sulimov, V. I. Makolkin | ||
| "... and 50 patients started to take emmetoprolol/em in initial dose of 50 mg twice daily. Duration of treatment ..." | ||
| Vol 2, No 2 (2006) | CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION | Abstract similar documents |
| V. E. Oleynikov, V. A. Budanova, A. V. Kulucin | ||
| "... Aim. To study antihypertensive efficacy of long-acting emmetoprolol/em, its influence on heart rate ..." | ||
| Vol 4, No 5 (2008) | CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... for comparable study of efficacy and safety of therapies based on β-blockers (carvedilol and emmetoprolol/em ..." | ||
| Vol 3, No 4 (2007) | EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova | ||
| "... emmetoprolol/em. Echocardiography, 6-minute walk test were applied. Blood levels of primary and secondary lipid ..." | ||
| Vol 6, No 4 (2010) | HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD | Abstract PDF (Eng) similar documents |
| A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov | ||
| "... , emmetoprolol/em, simvastatin) during 2 years after discharge from the hospital. Patients of the first studied ..." | ||
| Vol 5, No 2 (2009) | EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| G. F. Andreeva, A. D. Deev, V. M. Gorbunov | ||
| "... received antihypertensive monotherapy with diltiazem, amlodipine, enalapril, lisinopril, emmetoprolol/em ..." | ||
| Vol 3, No 1 (2007) | RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY | Abstract similar documents |
| M. L. Maximov | ||
| "... of emmetoprolol/em, bisoprolol and carvedilol had been proven in CHF therapy. Nebivolol was effective in elderly ..." | ||
| Vol 4, No 4 (2008) | INFLUENCE OF ABDOMINAL OBESITY ON HEART STRUCTURAL AND FUNCTIONAL CHANGES AND POSSIBILITY OF THEIR PHARMACOLOGICAL CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| V. R. Veber, M. P. Rubanova, M. N. Kopina, S. V. Zhmajlova, D. P. Shmatko, I. V. Prozorova | ||
| "... and echocardiography examination was performed before and after 1, 3 and 6 months of therapy (emmetoprolol/em, nebivolol ..." | ||
| Vol 4, No 3 (2008) | URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES | Abstract similar documents |
| M. P. Savenkov, A. S. Volkova, A. V. Kirienko, S. N. Ivanov, S. V. Ivanov | ||
| "... , emmetoprolol/em, nebivolol) in patients with arterial hypertension (HT) and concomitant benign prostatic ..." | ||
| Vol 4, No 3 (2008) | INFLUENCE OF COMBINED ANTIHYPERTENSIVE AND ANTIDEPRESSANT THERAPY ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION, ANXIETY AND DEPRESSION | Abstract similar documents |
| Y. A. Vasyuk, T. V. Dovzenko, E. A. Nesterova, I. A. Sadulaeva, K. V. Tarasova | ||
| "... Aim. To assess influence of combined antihypertensive (captopril or emmetoprolol/em) and antidepressant ..." | ||
| Vol 8, No 3 (2012) | EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva | ||
| "... (5–10 mg/day) in combination with indapamide retard (1.5 mg/day) and emmetoprolol/em succinate (50–100 mg ..." | ||
| Vol 18, No 5 (2022) | Comparative Pharmacoepidemiological Assessment of Antihypertensive Drugs Administration Structure in Pregnant Women in Routine Medical Practice in Kursk and Chisinau | Abstract similar documents |
| S. V. Povetkin, V. I. Gikavyj, N. G. Bachinski, O. V. Levashova, A. A. Kornilov, L. A. Podgurski, L. M. Tsurkan | ||
| "... , doctors most often prescribed bisoprolol (43.3%), emmetoprolol/em (21.7%) and nebivolol (13.3%), while ..." | ||
| Vol 4, No 3 (2008) | HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA | Abstract similar documents |
| A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova | ||
| "... and various beta-blockers (atenolol, emmetoprolol/em, bisoprolol). These beta-blockers were changed for carvedilol ..." | ||
| Vol 20, No 5 (2024) | Early intravenous beta-blockers injection in patients with acute STEMI: the results of the Russian registry REGION-IM | Abstract similar documents |
| T. S. Sukhinina, M. A. Terenicheva, R. G. Gulyan, R. M. Shakhnovich, O. V. Stukalova, O. A. Saygina, I. S. Yavelov, D. V. Pevsner | ||
| "... ) of patients with STEMI received IVF therapy. In all cases, emmetoprolol/em was used at an average daily dose of 4 ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... (55.0%) occupied the leading position in the group of beta-blockers. emMetoprolol’s/em prescription rate ..." | ||
| Vol 14, No 2 (2018) | THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT | Abstract similar documents |
| M. S. Soboleva, Е. E. Loskutova | ||
| "... drugs was studied. Results. Among β-blockers the leaders were emmetoprolol/em (from 2% to 30 ..." | ||
| Vol 15, No 4 (2019) | Antihypertensive Drug Utilization in Two Districts of Northern Cyprus | Abstract PDF (Eng) similar documents |
| M. Tamirci, R. Demirdamar | ||
| "... . According to the ATC-5 subclassification, the most common prescribed antihypertensives were emmetoprolol/em (16 ..." | ||
| Vol 15, No 2 (2019) | Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov | ||
| "... for patients after AMI, the second place took emmetoprolol/em, its prescription was two times less than bisprolol ..." | ||
| Vol 5, No 4 (2009) | THE CAMELLIA TRIAL: SCIENTIFIC VALUE AND RECOMMENDS FOR PRACTITIONER | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, S. A. Shalnova, R. G. Oganov | ||
| "... карведилоле и emметопрололе/em. ..." | ||
| Vol 15, No 5 (2019) | Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis | Abstract similar documents |
| L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok | ||
| "... group were older than these in the first group (p0.em001/em). Patients of the group 1 compared to the group ..." | ||
| Vol 17, No 3 (2021) | The Effect of Clinical Characteristics and Stent Parameters on Left Ventricular Mechanical Dyssynchrony | Abstract PDF (Eng) similar documents |
| S. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... after PCI TSI improved significantly to 163.7±17.6 ms (p0.em001/em), 3 months after PCI showed more ..." | ||
| Vol 9, No 1 (2013) | FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Ya. Bart, E. A. Vartanyan | ||
| "... (p0.em001/em), they were more often diagnosed with left ventricular aneurysm (p=0.em001/em), chronic kidney ..." | ||
| Vol 13, No 4 (2017) | COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina | ||
| "... ) variability at night (p0.05) and a morning surge in SBP (pem0.01/em), end systolic volume (p0.05), systolic ..." | ||
| Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
| O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
| "... with myocardial infarction (MI) according to RECORD-3 are more often male smokers (p=0.em001/em) with a heredity ..." | ||
| Vol 5, No 5 (2009) | EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE | Abstract PDF (Eng) similar documents |
| V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev | ||
| "... -diastolic dimension (p0,em001/em), end-systolic dimension (p0,em001/em), left atrium (p=0,004), end-diastolic vol ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY | Abstract similar documents |
| E. V. Goncharova, A. V. Govorin | ||
| "... with cardiomyopathy. Flow rate rapid filling re- duced by 27.1% compared with this in control (p0.em001/em), and flow rate ..." | ||
| Vol 16, No 3 (2020) | The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention | Abstract PDF (Eng) similar documents |
| Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
| "... .94%. One month after PCI, mean GLPSS improved significantly to -14.05±1.72% (p0.em001/em), 3 months after PCI ..." | ||
| Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... .8±8.4 and -30.4±12.8/18.7±8 mm Hg for groups 1 and 2, respectively , p0.em001/em for the both groups ..." | ||
| Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
| K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
| "... : +52.3%, p0.em001/em) in the main cohort and from 12.3% to 19.8% (+61.7%, p0.em001/em) in the additional cohort ..." | ||
| Vol 12, No 6 (2016) | EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... myocardial mass (from 170 [225.5;213.5] to 159 [146;167] g; p0.em001/em), and size of the left atrium (LA; from ..." | ||
| Vol 10, No 3 (2014) | EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... 0.em001/em) were revealed. The right ventricle increased in size with the impairment of its diastolic ..." | ||
| Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
| I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
| "... of the treatments was also assessed. Results. Group 1: the average CHF class (NYHA) decreased by 20.7% (pem0.01/em), EF ..." | ||
| Vol 12, No 6 (2016) | Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova | ||
| "... .356; p=0.011), CRP level (R=0.442; p=0.em001/em), the sizes of both atria (p0.em001/em), isovolumic relaxation ..." | ||
| Vol 12, No 1 (2016) | Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease | Abstract PDF (Eng) similar documents |
| E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova | ||
| "... .356; p=0.011), CRP level (R=0.442; p=0.em001/em), the sizes of both atria (p0.em001/em), isovolumic relaxation ..." | ||
| Vol 7, No 5 (2011) | EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY | Abstract similar documents |
| V. M. Provotorov, S. A. Avdeeva | ||
| "... increase in hemoglobin (+12.5%; p0.em001/em) and hematocrit (+5.8%; p0.em001/em) levels, as well as increase in red ..." | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE | Abstract similar documents |
| R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov | ||
| "... in 24 hrs. (from 141.9±1.9 to 128.6±0.8 mmHg, p0.em001/em), in daytime (from 146.8±2.6 to 135.8±1.0 mmHg, p ..." | ||
| Vol 15, No 6 (2019) | Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) | Abstract similar documents |
| D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash | ||
| "... disease and polyvascular disease (р=0.002), prior angina pectoris (р=0.em001/em), as well as the course ..." | ||
| Vol 15, No 3 (2019) | Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... valve in patients of groups 1 and 2 was lower than in the control by 15% and 17%, respectively (p0.em001/em ..." | ||
| Vol 19, No 2 (2023) | Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization | Abstract similar documents |
| D. P. Golubovskaya, V. N. Karetnikova, A. B. Osokina, I. P. Oleinik, O. L. Barbarash | ||
| "... , only in the main group there was an improvement in all clinical indicators (pem0.01/em), an increase ..." | ||
| Vol 14, No 2 (2018) | SINGLE AND MULTIPLE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING | Abstract similar documents |
| E. S. Bulgakova, T. V. Tvorogova, В. A. Rudenko, O. М. Drapkina | ||
| "... patients (n=84) microlesion count correlated with age (γ=0.243; pem0.01/em), preprocedural hemoglobin level (γ ..." | ||
| Vol 18, No 4 (2022) | Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, A. V. Zagrebelnyy, Yu. V. Lukina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, S. V. Blagodatskikh, I. V. Budaeva, E. S. Nekoshnova, O. M. Drapkina | ||
| "... with the frequency of UA control (p0.em001/em). In patients with AH, an increase in the level of sUA was detected ..." | ||
| Vol 19, No 1 (2023) | Associations of Arterial Stiffness and Bone Mineral Density in Postmenopausal Women | Abstract similar documents |
| O. Yu. Isaykina, I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, V. E. Novikov, T. T. Tsoriev | ||
| "... (rs=0.12, p0.05); a more pronounced negative correlation was obtained for BMD (rs=0.16, pem0.01/em ..." | ||
| Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY | Abstract similar documents |
| V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik | ||
| "... . SBP decreased by 37,5 mm Hg (рem0,01/em) in smoking patients and by 37,6 mm Hg (рem0,01/em) in non-smoking ..." | ||
| Vol 6, No 1 (2010) | ACTOVEGIN INFLUENCE ON METABOLIC AND VASOMOTOR FUNCTION OF MICROVASCULAR ENDOTHELIAL OF HUMAN SKIN | Abstract similar documents |
| A. A. Fedorovich, A. N. Rogoza, E. M. Kanisheva, S. A. Boytsov | ||
| "... increased in maximal amplitude endothelial rhythm (at a frequency of em0.01/em Hz) by 76% (p0,em001/em ..." | ||
| Vol 6, No 4 (2010) | EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA | Abstract similar documents |
| P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev | ||
| "... application led to significant reduction in levels of TC (from 247.1±27 to 186.5±12 mg/dl; p0.em001/em), LDC (from ..." | ||
| Vol 6, No 5 (2010) | INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract PDF (Eng) similar documents |
| E. N. Golovenko, D. A. Napalkov, V. A. Sulimov | ||
| "... (FC) III-IV than in those with CHF of FC I-II (p0.em001/em). Negative correlation was revealed between TrI ..." | ||
| Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... simvastatin TC decreased from 6.4±0.8 to 4.4±0.6 mmol/l (p0.em001/em) and from 6.0±0.7 to 4.1±0.7 mmol/l (p0.em001/em ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... (TTR≥65%) were younger (p0.em001/em), more often men (p0.074) with a high level of education (p0.em001/em ..." | ||
| Vol 8, No 2 (2012) | SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS | Abstract similar documents |
| I. S. Dzherieva, N. I. Volkova, S. I. Rapoport | ||
| "... higher than that in employees with steady work schedule (34.4 vs 27.4%, respectively; рem0.01/em ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| "... , triglyceride (p0.em001/em) and significant increase in high-density lipoprotein cholesterol (p0.em001/em) when compared ..." | ||
| Vol 16, No 5 (2020) | Atrial Fibrillation: the Association with Physical Activity and the Effects of Cardiac Rehabilitation | Abstract similar documents |
| M. G. Bubnova, D. M. Aronov | ||
| "... of physical training in patients with AF after RFA: increase in exercise duration by 18.6% (p0.em001/em) and load ..." | ||
| Vol 18, No 1 (2022) | Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery | Abstract PDF (Eng) similar documents |
| O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin | ||
| "... was 39.3% higher (p=0.em001/em), interleukin-10 – 20.2% higher (p=em0.01/em), superoxide dismutase – 78.9% higher ..." | ||
| Vol 15, No 1 (2019) | Prognostic Value of ECG in Patients with Pulmonary Embolism | Abstract similar documents |
| I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov | ||
| "... -complete right bundle branch block (RBBB) (16.3 vs 37.9%; p=0.em001/em), ST segment elevation in lead III (9 ..." | ||
| Vol 15, No 2 (2019) | Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... - 0.9 [0.8;1.31 ], in the 2nd group - 0.8 [0.78; 1.2] with a control value of 1.6 [1.2;1.94] (p0.em001/em ..." | ||
| Vol 17, No 6 (2021) | Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Yu. E. Tatsiy, S. A. Boytsov, O. M. Drapkina | ||
| "... a higher risk of thromboembolic complications (CHA2DS2-VASc – 4.68±1.59 and 3.10±1.50; p0.em001/em ..." | ||
| Vol 13, No 5 (2017) | COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES | Abstract similar documents |
| A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash | ||
| "... and more often had excess body weight (p0.em001/em). The majority of current smokers were males (p0.em001/em ..." | ||
| Vol 14, No 1 (2018) | STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY) | Abstract similar documents |
| S. V. Povetkin, Ju. V. Luneva | ||
| "... 83.0±6.18 to 67.6±5.97 beats/min in the 2nd group, pem0.01/em for both) and in blood pressure level ..." | ||
| Vol 11, No 3 (2015) | THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION | Abstract similar documents |
| I. L. Tepoyan, D. V. Nebieridze, I. A. Skripnikova, A. S. Safaryan, V. A. Vygodin, V. E. Novikov, L. M. Murashko | ||
| "... increase in BMD in the spine according to the T-test from -1.7±0.4 SD to -1.4±0.53 SD (p0.em001/em), while ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... density cholesterol (LDC) by 52.4% (p0.em001/em) was found after 24 weeks in Group 1. Achieving the target LDC ..." | ||
| Vol 6, No 4 (2010) | COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov | ||
| "... reduction from 98.6±2.5 to 58.6±3.5 bt/min (р0.em001/em) was found with the 24 hour electrocardiogram-monitoring ..." | ||
| Vol 18, No 5 (2022) | Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 | Abstract similar documents |
| A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina | ||
| "... . The age of post-COVID patients with CVMM was 73.7±9.6 years, without CVD – 49.4±12.4 years (p0.em001/em ..." | ||
| Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
| I. V. Sergienko, A. A. Ansheles | ||
| "... .3%, "probable" – 18.1%. Patients with definite FH diagnosis showed higher level of TCh (p0.em001/em), LDL ..." | ||
| Vol 4, No 5 (2008) | COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS | Abstract similar documents |
| S. N. Tolpygina, S. Y. Martsevich | ||
| "... ) and LDL cholesterol reduced on 25,2% and 33,6% (p0,em001/em), respectively. Next 6 weeks of therapy ..." | ||
| Vol 8, No 6 (2012) | THE EFFECT OF MAGNESIUM DRUGS ON THE PHYSICAL PERFORMANCE OF YOUNG PEOPLE WITH MITRAL VALVE PROLAPSE: RESULTS OF NONCOMPARATIVE STUDY | Abstract similar documents |
| K. M. Dzeranova, A. G. Avtandilov, N. V. Vertkina | ||
| "... product elevated from 1.86±0.05 to 2.06±0.05 units (p0.em001/em); threshold power increased - relative ..." | ||
| Vol 4, No 2 (2008) | MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY | Abstract similar documents |
| L. G. Voronkov, A. A. I.Shkurat, E. A. Lutsak | ||
| "... than this in control group (pem0,01/em) during RH test. After mildronate infusion increase in %∆D during RH ..." | ||
| Vol 12, No 5 (2016) | Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention | Abstract similar documents |
| E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva | ||
| "... 12 Reaction Units (PRU) according to VerifyNow® (p=em0.01/em), number of stented arteries more than 2 (p=em0.01/em ..." | ||
| Vol 13, No 1 (2017) | CHANGE OF ARRHYTHMIC EVENTS IN ACUTE MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION AFTER PHARMACOINVASIVE REVASCULARIZATION | Abstract similar documents |
| V. E. Oleynikov, E. A. Shigotarova, A. V. Kulyutsin, E. V. Dushina, J. A. Guskova | ||
| "... with an increased incidence of ventricular tachycardia (VT) (pem0.01/em), sinus tachycardia (p=em0.01/em), paroxysmal ..." | ||
| Vol 13, No 4 (2017) | OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT | Abstract similar documents |
| I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova | ||
| "... and hypertriglyceridemia was similar in the compared groups of patients with MS regardless of the presence of gout (p0.em001/em ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... (compensated) of LV remodeling increased by 18% (p0.em001/em) in group A2, and by 6%, (p=0.03) in group A1. After ..." | ||
| Vol 7, No 6 (2011) | MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS | Abstract similar documents |
| N. S. Chipigina, G. M. Urvacheva, N. A. Shostak, I. V. Zhitareva, I. Yu. Zhitomirskaya | ||
| "... associations of MAC presence with symptomatic atherosclerotic peripheral arterial disease (p 0.em001/em; ß=0 ..." | ||
| Vol 8, No 5 (2012) | HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... with the control group women had higher values of minimum (52.3±0.4 vs 47.5±0.4; p0.em001/em) and mean (78.5±0.5 vs 75 ..." | ||
| Vol 14, No 5 (2018) | Dynamics of Carotid Intima-Media Thickness, Parameters of Arterial Stiffness and Ambulatory Blood Pressure Monitoring during Therapy with Inhibitor of Tumor Necrosis Factor-Alpha in Patients with Early Psoriatic Arthritis | Abstract similar documents |
| E. I. Markelova, D. S. Novikova, T. V. Korotaeva, E. Yu. Loginova | ||
| "... values: DAS decreased from 4.6 (2.9; 1.9) to 1.6 (1.3; 1.9), p=0,em001/em; HAQ from 0.93 (0.81; 1.31) to 0 ..." | ||
| Vol 15, No 5 (2019) | Left Atrial Phasic Function in Patients with Hypertension and Recurrent Atrial Fibrillation: Gender Differences of the Relationship with Diastolic Dysfunction and Central Aortic Pressure | Abstract similar documents |
| E. V. Kokhan, E. M. Ozova, V. A. Romanova, G. K. Kiyakbaev, Zh. D. Kobalava | ||
| "... [42;55]%; p=0.02) and E/E’(9.7 [7.8;12] vs 7.1 [5.6;8.6]; p=0.em001/em) were worse than in men. Active LA ..." | ||
| Vol 18, No 1 (2022) | Preventive Screening of Young People from the Perspective of Vascular Aging Phenotypes: the Role of Body Weight | Abstract similar documents |
| M. Y. Evsevyeva, M. V. Eremin, M. V. Rostovtseva, O. V. Sergeeva, A. V. Rusidi, V. D. Kudryavtseva, E. V. Shchetinin | ||
| "... was significant for CAVI with a weight -0.428 (p0.em001/em) for R-CAVI, -0.453 (p0.em001/em) for L- CAVI, and even more ..." | ||
| 1 - 100 of 331 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
